Michele Tedeschi
Michele Tedeschi has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Valentina Ferraro
Department of Hepato-Pancreatic-Biliary Surgery, Miulli Hospital, Bari, Italy
2 shared publications A. Gentile
General Surgery and Liver Transplantation Division, D.E.T.O., Università di Bari, Italy
1 shared publication- Adelmo Antonucci
Department of Surgery, Monza Polyclinic, 20900 Monza, Italy
1 shared publication - Alba Fiorentino
Radiation Oncology Department, General Regional Hospital F. Miulli, Acquaviva delle fonti, Italy
1 shared publication - Albert Troci
Department of Surgery, L. Sacco Hospital, Milan, Italy
1 shared publication - Alberto Manzoni
Department of General Surgery, Poliambulanza Foundation Hospital, 25136 Brescia, Italy
1 shared publication
Latest Publications
- 27 February 2021
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 22 (4) , 1-9
The Role of Laparoscopic Surgery in Localized Pancreatic Neuroendocrine Tumours
Opinion statement Pancreatic neuroendocrine tumours (PNETs) are a rare and heterogeneous group of tumours with various clinical manifestations and biological behaviours. They represent approximately 2–4% of all pancreatic tumours, with an incidence of 2–3 cases per million people. PNETs are classified clinically as non-functional or functional, and pancreatic resection is recommended for lesions greater than 2 cm. The surgical approach can involve “typical” and “atypical” resections depending on the number, size and location of the tumour. Typical resections include pancreaticoduodenectomy, distal pancreatectomy enucleation and, rarely, total pancreatectomy. Atypical resections comprise central pancreatectomies or enucleations. Minimally invasive pancreatic resection has been proven to be technically feasible and safe in high-volume and specialized centres with highly skilled laparoscopic surgeons, with consolidated benefits for patients in the postoperative course. However, open and minimally invasive pancreatic surgery remains to have a high rate of complications; there is no specific technical contraindication to minimally invasive pancreatic surgery, but an appropriate patient selection is crucial to obtain satisfactory clinical and oncological outcomes.
- 27 February 2021
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 22 (4) , 1-9
The Role of Laparoscopic Surgery in Localized Pancreatic Neuroendocrine Tumours
Opinion statement Pancreatic neuroendocrine tumours (PNETs) are a rare and heterogeneous group of tumours with various clinical manifestations and biological behaviours. They represent approximately 2–4% of all pancreatic tumours, with an incidence of 2–3 cases per million people. PNETs are classified clinically as non-functional or functional, and pancreatic resection is recommended for lesions greater than 2 cm. The surgical approach can involve “typical” and “atypical” resections depending on the number, size and location of the tumour. Typical resections include pancreaticoduodenectomy, distal pancreatectomy enucleation and, rarely, total pancreatectomy. Atypical resections comprise central pancreatectomies or enucleations. Minimally invasive pancreatic resection has been proven to be technically feasible and safe in high-volume and specialized centres with highly skilled laparoscopic surgeons, with consolidated benefits for patients in the postoperative course. However, open and minimally invasive pancreatic surgery remains to have a high rate of complications; there is no specific technical contraindication to minimally invasive pancreatic surgery, but an appropriate patient selection is crucial to obtain satisfactory clinical and oncological outcomes.
- Open Access
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma
Background: We aimed to assess the ability of comprehensive complication index (CCI) and Clavien-Dindo complication (CDC) scale to predict excessive length of hospital stay (e-LOS) in patients undergoing liver resection for hepatocellular carcinoma. Methods: Patients were identified from an Italian multi-institutional database and randomly selected to be included in either a derivation or validation set. Multivariate logistic regression models and ROC curve analysis including either CCI or CDC as predictors of e-LOS were fitted to compare predictive performance. E-LOS was defined as a LOS longer than the 75th percentile among patients with at least one complication. Results: A total of 2669 patients were analyzed (1345 for derivation and 1324 for validation). The odds ratio (OR) was 5.590 (95%CI 4.201; 7.438) for CCI and 5.507 (4.152; 7.304) for CDC. The AUC was 0.964 for CCI and 0.893 for CDC in the derivation set and 0.962 vs. 0.890 in the validation set, respectively. In patients with at least two complications, the OR was 2.793 (1.896; 4.115) for CCI and 2.439 (1.666; 3.570) for CDC with an AUC of 0.850 and 0.673, respectively in the derivation cohort. The AUC was 0.806 for CCI and 0.658 for CDC in the validation set. Conclusions: When reporting postoperative morbidity in liver surgery, CCI is a preferable scale.
Open AccessPerformance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma
Background: We aimed to assess the ability of comprehensive complication index (CCI) and Clavien-Dindo complication (CDC) scale to predict excessive length of hospital stay (e-LOS) in patients undergoing liver resection for hepatocellular carcinoma. Methods: Patients were identified from an Italian multi-institutional database and randomly selected to be included in either a derivation or validation set. Multivariate logistic regression models and ROC curve analysis including either CCI or CDC as predictors of e-LOS were fitted to compare predictive performance. E-LOS was defined as a LOS longer than the 75th percentile among patients with at least one complication. Results: A total of 2669 patients were analyzed (1345 for derivation and 1324 for validation). The odds ratio (OR) was 5.590 (95%CI 4.201; 7.438) for CCI and 5.507 (4.152; 7.304) for CDC. The AUC was 0.964 for CCI and 0.893 for CDC in the derivation set and 0.962 vs. 0.890 in the validation set, respectively. In patients with at least two complications, the OR was 2.793 (1.896; 4.115) for CCI and 2.439 (1.666; 3.570) for CDC with an AUC of 0.850 and 0.673, respectively in the derivation cohort. The AUC was 0.806 for CCI and 0.658 for CDC in the validation set. Conclusions: When reporting postoperative morbidity in liver surgery, CCI is a preferable scale.
- 3 April 2014
- Published by Springer Nature
- p. 201-218
Intraoperative and Laparoscopic Ultrasound During Liver Surgery
- 3 April 2014
- Published by Springer Nature
- p. 201-218
Intraoperative and Laparoscopic Ultrasound During Liver Surgery
- Open Access
- 31 December 2009
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 18 (6) , e63-e65
Large Isolated Hypogastric Artery Aneurysm Compressing Both Pelvic Ureters
- 31 December 2009
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 18 (6) , e63-e65
Open AccessLarge Isolated Hypogastric Artery Aneurysm Compressing Both Pelvic Ureters